Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 55Multiple Myeloma 53Hodgkin Disease 51Precursor Cell Lymphoblastic Leukemia-Lymphoma 48Lymphoma, Non-Hodgkin 46Leukemia, Lymphocytic, Chronic, B-Cell 44Myelodysplastic Syndromes 41Lymphoma, Mantle-Cell 39Lymphoma, Large B-Cell, Diffuse 38Lymphoma, Follicular 36Leukemia 36Congenital Abnormalities 36Burkitt Lymphoma 34Myeloproliferative Disorders 31Lymphoma 30Lymphoma, B-Cell, Marginal Zone 29Lymphoma, Large-Cell, Immunoblastic 28Leukemia, Myeloid, Accelerated Phase 27Leukemia, Myeloid, Chronic-Phase 26Waldenstrom Macroglobulinemia 25Blast Crisis 25Leukemia, Myelomonocytic, Chronic 24Recurrence 19Primary Myelofibrosis 19Lymphoma, T-Cell, Cutaneous 19Neoplasms, Plasma Cell 18Lymphoma, Large-Cell, Anaplastic 18Myelodysplastic-Myeloproliferative Diseases 16Sezary Syndrome 15Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 15

Interventions

Voriconazole 2Daptomycin 2threonic acid 1telavancin 1telaprevir 1soybean oil, phospholipid emulsion 1plerixafor 1peginterferon alfa-2a 1human papillomavirus vaccine, L1 type 16, 18 1fludarabine phosphate 1Whole-Body Irradiation 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Tacrolimus 1Sulfamethoxazole 1Sirolimus 1Rituximab 1Ribavirin 1Peripheral Blood Stem Cell Transplantation 1Ofloxacin 1Methotrexate 1Melphalan 1Magnesium Sulfate 1Human Papillomavirus Recombinant Vaccine nonavalent 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Hematopoietic Stem Cell Transplantation 1Granulocyte Colony-Stimulating Factor 1Fluconazole 1Filgrastim 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Infections × Peripheral Blood Stem Cell Transplantation × Clear all
NCT00589563 2014-09-10

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer

City of Hope Medical Center

Phase 2 Completed
32 enrolled 24 charts
DermatologicLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Congenital Abnormalities, Burkitt Lymphoma, Graft vs Host Disease, Hodgkin Disease, Immunoblastic Lymphadenopathy, Infections, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Precancerous Conditions, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡